Nuveen Asset Management, LLC Karyopharm Therapeutics Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.72 - $1.66 $27,405 - $63,184	38,063 Added 8.38%	492,365 $743,000
Q4 2023 Feb 14, 2024	BUY	$0.68 - $1.31 $1,289 - $2,483	1,896 Added 0.42%	454,302 $390,000
Q3 2023 Nov 14, 2023	SELL	$1.14 - $1.81 $12,685 - $20,141	-11,128 Reduced 2.4%	452,406 $606,000
Q2 2023 Aug 14, 2023	SELL	$1.79 - $4.59 $2.35 Million - $6.04 Million	-1,314,998 Reduced 73.94%	463,534 $829,000
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $524,894 - $724,502	184,822 Added 11.6%	1,778,532 $6.92 Million
Q4 2022 Feb 14, 2023	SELL	$2.48 - $5.93 $935,798 - $2.24 Million	-377,338 Reduced 19.14%	1,593,710 $5.42 Million
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $308,733 - $440,399	75,670 Added 3.99%	1,971,048 $10.8 Million
Q2 2022 Aug 15, 2022	BUY	$4.15 - $8.37 $316,769 - $638,882	76,330 Added 4.2%	1,895,378 $8.55 Million
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $3.75 Million - $9.13 Million	634,738 Added 53.6%	1,819,048 $11.9 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $340,223 - $562,250	65,302 Added 5.84%	1,184,310 $6.72 Million
Q3 2021 Nov 12, 2021	SELL	$4.45 - $10.63 $75,240 - $179,732	-16,908 Reduced 1.49%	1,119,008 $6.79 Million
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $1.67 Million - $2.29 Million	206,355 Added 22.2%	1,135,916 $11.7 Million
Q1 2021 May 17, 2021	SELL	$9.85 - $17.69 $965,565 - $1.73 Million	-98,027 Reduced 9.54%	929,561 $9.78 Million
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $348,769 - $423,699	-24,648 Reduced 2.34%	1,027,588 $15.9 Million
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $8.9 Million - $12.4 Million	629,490 Added 148.91%	1,052,236 $15.4 Million
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $2.3 Million - $3.5 Million	138,527 Added 48.74%	422,746 $8.01 Million
Q1 2020 May 14, 2020	SELL	$14.38 - $27.72 $2.56 Million - $4.94 Million	-178,128 Reduced 38.53%	284,219 $5.46 Million
Q4 2019 Feb 14, 2020	BUY	$9.23 - $19.67 $589,095 - $1.26 Million	63,824 Added 16.02%	462,347 $8.86 Million
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $72,538 - $151,869	12,816 Added 3.32%	398,523 $3.83 Million
Q2 2019 Aug 15, 2019	BUY	$4.32 - $6.43 $1.67 Million - $2.48 Million	385,707 New	385,707 $2.31 Million

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$5.13 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.72 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.42 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.89 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.79 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $53.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account